Trovagene Q1 Revenues Down 7 Percent, Net Loss Increases Sharply | GenomeWeb

NEW YORK (GenomeWeb) – Trovagene reported after the close of the market on Monday a 7 percent decline year over year in revenues for the first quarter, as well as a steep increase in its net loss.

The San Diego developer of cell-free molecular diagnostics said that for the three months ended March 31, revenues shrank to $111,000 from $119,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.